SecBot SecBot
6-K ·Filed Oct 2, 2026

CUVL

Clinuvel Pharmaceuticals Ltd
NEUTRAL
Impact 2/10
Horizonweeks Processed25d 1h ago SEC0001493152-26-045459
Notable filing: 6-K
Actionable Insight • Neutral

Routine AGM notice filing — no actionable trading signal. Monitor the AGM results and any subsequent 6-K for material updates on corporate strategy or financial outlook.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
CUVL ▼ -7.30% at T+5d
NEUTRAL call -7.30% · α vs SPY -8.46% · entry $6.03 → $5.59
Next anchor: T+20d in 3d
Latest observation: T+15 -15.76% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
-4.81%
call -4.81% · α -5.48%
$5.74
settled 22d ago
T+5d
-7.30%
call -7.30% · α -8.46%
$5.59
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Clinuvel Pharmaceuticals filed a Form 6-K with the SEC on October 2, 2026, to report that it had filed its Notice of Annual General Meeting and Proxy Form with the Australian Securities Exchange on October 1, 2026. The filing is a routine procedural disclosure with no material financial or operational information.

Key Facts

  • Filed a Form 6-K on October 2, 2026
  • Reports filing of Notice of Annual General Meeting and Proxy Form with the ASX on October 1, 2026
  • No financial data, guidance, or material business developments disclosed

Financial Impact

No financial impact — routine procedural filing

Risk Factors

  • No material risks identified from this filing

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-045459
Document: 0001493152-26-045459-index-headers.html0001493152-26-045459
Document: 0001493152-26-045459-index.html0001493152-26-045459
Document: 0001493152-26-045459.txt0001493152-26-045459
8 reports for CUVL
Performance horizon
Filters
Rows
Reports for CUVL — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
6-K
NEUTRAL ★ 2/10
$5.06awaiting T+20—$4.98 (−1.58%)
Oct 7, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$5.80awaiting T+20—$4.98 (−14.14%)
Oct 2, 2026
25d ago
6-K
NEUTRAL ★ 2/10
$6.03awaiting T+20—$4.98 (−17.41%)
Oct 1, 2026
26d ago
6-K
NEUTRAL ★ 3/10
$5.66awaiting T+20—$4.98 (−12.01%)
Aug 27, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$6.77 $5.78▼ −14.62%▼ −14.12%$4.98 (−26.44%)
Aug 27, 2026
8w ago
Press Release
MIXED ★ 5/10
$6.77 $5.78▼ −14.62%▼ −14.12%$4.98 (−26.44%)
Aug 20, 2026
9w ago
6-K
NEUTRAL ★ 2/10
$7.80 $5.90▼ −24.36%▼ −24.36%$4.98 (−36.15%)
Jul 23, 2026
13w ago
6-K
MIXED ★ 5/10
$6.95 $7.80▲ +12.23%▲ +8.92%$4.98 (−28.35%)
Showing 8 of 8

US Market Status

Market Open — Closes in 3h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026